Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum

dc.authorid0000-0002-3234-3943
dc.authorid0000-0002-5293-6447
dc.authorid0000-0001-6480-855X
dc.contributor.authorYonar, Dilek
dc.contributor.authorSevercan, Mete
dc.contributor.authorGurbanov, Rafig
dc.contributor.authorSandal, Abdulsamet
dc.contributor.authorYilmaz, Ulku
dc.contributor.authorEmri, Salih
dc.contributor.authorSevercan, Feride
dc.date.accessioned2025-05-20T18:59:21Z
dc.date.issued2022
dc.departmentBilecik Şeyh Edebali Üniversitesi
dc.description.abstractMalignant pleural mesothelioma (MPM), an aggressive cancer associated with exposure to fibrous minerals, can only be diagnosed in the advanced stage because its early symptoms are also connected with other respiratory diseases. Hence, understanding the molecular mechanism and the discrimination of MPM from other lung dis-eases at an early stage is important to apply effective treatment strategies and for the increase in survival rate. This study aims to develop a new approach for characterization and diagnosis of MPM among lung diseases from serum by Fourier transform infrared spectroscopy (FTIR) coupled with multivariate analysis. The detailed spectral characterization studies indicated the changes in lipid biosynthesis and nucleic acids levels in the ma-lignant serum samples. Furthermore, the results showed that healthy, benign exudative effusion, lung cancer, and MPM groups were successfully separated from each other by applying principal component analysis (PCA), support vector machine (SVM), and especially linear discriminant analysis (LDA) to infrared spectra.
dc.description.sponsorshipTUBITAK, Scientific and Technological Research Council of Turkey [SBAG-113S294]; Scientific and Technological Research Council of Turkey
dc.description.sponsorshipWe would like to thank TUBITAK, The Scientific and Technological Research Council of Turkey, for providing financial support to the project numbered SBAG-113S294.
dc.identifier.doi10.1016/j.bbadis.2022.166473
dc.identifier.issn0925-4439
dc.identifier.issn1879-260X
dc.identifier.issue10
dc.identifier.pmid35753541
dc.identifier.scopus2-s2.0-85132845226
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.bbadis.2022.166473
dc.identifier.urihttps://hdl.handle.net/11552/8381
dc.identifier.volume1868
dc.identifier.wosWOS:000826690300001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWoS
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakWoS - Science Citation Index Expanded
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofBiochimica Et Biophysica Acta-Molecular Basis of Disease
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250518
dc.subjectMesothelioma
dc.subjectLung cancer
dc.subjectBlood serum
dc.subjectSpectral biomarkers
dc.subjectATR-FTIR spectroscopy
dc.subjectMultivariate analysis
dc.titleRapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Makale.pdf
Boyut:
4.93 MB
Biçim:
Adobe Portable Document Format